Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Osteoporosis 1Osteonecrosis 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Humoral Hypercalcemia Of Malignancy 1

Interventions

parathyroid hormone-related peptide (1-36) 1Zoledronic Acid 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Humoral Hypercalcemia Of Malignancy × Zoledronic Acid × Clear all
NCT00301886 2013-11-13

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 3 Withdrawn
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡